This allows patients and healthcare providers to weigh the benefits against potential risks and choose the most appropriate course of action
The APC said in an email to clients over the weekend that its working with lawyers to get clarity on whether the FDAs new filing means that it will not take enforcement against all compounding pharmacies who make tirzepatide or just the plaintiffs in the lawsuit
Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or severe renal/hepatic impairment
Consider other antidiabetic therapies in patients with a history of pancreatitis
Beyond GI effects, patients should watch for: Headaches , particularly during the first two weeks and after dose escalations Insomnia or sleep disruption, which affects some patients more than others Muscle pain and body aches , often reported in the first week of a new dose Anxiety , which some patients experience as appetite suppression creates unfamiliar hunger signals Joint pain , reported less frequently but worth monitoring Injection site reactions , including redness, itching, and localized swelling Menstrual changes , as rapid weight loss and hormonal shifts can affect cycle regularity Fatigue , especially during the caloric restriction phase Hair loss , a known but usually temporary effect of significant weight loss If side effects become unmanageable at any dose, the microdose tirzepatide schedule offers an alternative approach
